Gregory Pickett, DO
Orthopaedic Surgery · Altus, OKNPI 1609831833
Payments from drug & device makers
Across 90 payments — averaging $72.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shoulder Innovations, Inc.$2K
- Lima USA, Inc.$1K
- Zimmer Biomet$1K
- Si-bone, Inc.$876
- Amgen$340
- Trice Medical, Inc.$164
- plus $734 from 11 others
What the payments were for
- Travel & lodging$3,26850%
- Food & beverage$3,21049%
- Gifts$391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shoulder Innovations, Inc. | 4 | $1,685 |
| Lima USA, Inc. | 4 | $1,442 |
| Zimmer Biomet | 15 | $1,276 |
| Si-bone, Inc. | 15 | $876 |
| Amgen | 19 | $340 |
| Trice Medical, Inc. | 1 | $164 |
| Pacira Therapeutics, Inc. | 8 | $138 |
| Pacira Pharmaceuticals Incorporated | 6 | $116 |
| Stryker | 3 | $113 |
| Pylant Medical | 3 | $108 |
| Solventum Corporation | 3 | $61 |
| Radius Health, Inc. | 3 | $60 |
| Treace Medical Concepts, Inc. | 2 | $50 |
| Organogenesis Inc. | 1 | $30 |
| Innovation Technologies Inc | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InSet System$1,645
- SMR Shoulder$1,383
- Persona Revision$985
- iFuse Implant$253
- Revision$127
How this compares
$6,517 in reported general payments places this provider in the 60th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 162 | $2,814 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 187 | $2,194 |
| Enoxaparin Sodium | 38 | $1,907 |
| Diclofenac Sodium | 27 | $709 |
| Gabapentin | 66 | $669 |
| Meloxicam | 113 | $579 |
| Ibuprofen | 29 | $316 |
| Cyclobenzaprine Hcl | 18 | $188 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $166 |
| IbuIbuprofen | 14 | $128 |
| Prednisone | 12 | $98 |
| Amoxicillin | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Altus
- Yogesh MittalTulsa$6.7M
- Andrew ParkinsonOklahoma City$3.1M
- Brian ChalkinTulsa$1.9M
- Carlan YatesOklahoma City$772K
- Bradley ReddickOklahoma City$573K
- Vytautas RingusNorman$332K
- Jason EmersonOklahoma City$189K
- Paul MaitinoOklahoma City$176K
- Sarat KunapuliTulsa$170K
- Ronald DumiganOklahoma City$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.